Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Products

Asthma and COPD Market Forecast


Published Date: June 2009
Published By: Datamonitor
Page Count: 264
Order Code: R313-52318
 
DescriptionTable of ContentsSimilar
Products

Introduction

Although the respiratory market has expanded considerably from 2004 to 2008, growth in the seven major markets is slowing down from 2009 to 2011, after which sales will decline due to patent expiries of leading brands. Growth is driven by the expansion of sales in existing classes, the launch of major new products with safety and convenience advantages, and the results of several landmark trials.

Reasons to Purchase
  • Identify key opportunities and threats that will impact the use and uptake of new and existing products
  • Quantify the future size and scope of the asthma/COPD market and predict the performance of key compounds
  • Understand critical success factors in growing and defending respiratory brand franchises from new entrants and generics
Please note: this is delivered as a Zip file.

Similar Products
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search


Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.


Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Published Oct 2009 by Datamonitor


Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld


Antidepressants Market Forecast
Published Oct 2009 by Datamonitor


Snapshots Bulgaria Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group


Snapshots France Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group


Snapshots Australia Pharmaceuticals 2009
Published Oct 2009 by Snapdata International Group


Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential
Published Oct 2009 by Datamonitor




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com